Water Treatment, Health and Environmental Engineering Specialists since 1998




for batch
volumes of
5 litres

Ionization Generators
for Batch Volumes,
eg: 20 litres

Industrial Ionization
for Disinfecting
Drinking Water,
Swimming Pools, Cooling Towers,
Evaporators, HVAC

Hard Water

Electro-Medical and
Energy Medicine

Contact Us

Sitemap of
All Our Pages


for Colloidal

for Commercial

for Industrial


Accessories for
Electro-Medical Products,
probes, electrodes, cables

Our External

Prices of
All Our

Domestic colloidal generators for colloidal silver,
tin, iron, platinum, titanium, etc.

Colloidal Electrodes

Colloidal Instructions

Colloidal Analysis

Conductivity for ppm

Industrial Water
Ionizers, Multichannel

Chlorine Dangers

Swimming Pool Disinfection Ionizers

Transcerebral Electro-Magnetic Brain Stimulation (TMS)

Hair Growth Electrical
Stimulator (ETG)

Magnetic Generators and Stimulators

Light and Laser Biophotonics

Frequency and Pulse Generators

Prostate Shrinker, Non-invasive Far Infrared (FIR)





















Our Prostatherm Prostate Shrinker uses non-invasive Electro-Magnetic Tumor Treating Fields (TTF), Far Infra-Red (FIR), Green Photonic Ray, Hyperthermia and Vibrational Frequencies in tumour treatment and prevention:

More information at prostate_reduce.html

Link to my video demonstrating the Prostatherm

The new Prostatherm emits 5 different therapeutic energies. Price = $1800 USD

Benign prostatic hyperplasia (BPH), or the noncancerous enlargement of the prostate gland, is a common condition associated with aging. While the prostate grows throughout a man’s lifetime, bothersome growth typically begins at age 40, and by approximately age 60 more than half of men will have experienced at least some symptoms of BPH; by age 80, up to 80% to 90% of men become symptomatic. It is estimated that nearly 15 million men in the United States and 30 million men worldwide experience symptoms of BPH; of this number, an estimated 25% require pharmaceutical or surgical treatment. Due to the aging of the population, the number of men with the condition is expected to follow an upward trend. This presents a significant unmet need for minimally invasive or less invasive BPH therapy as a less costly, more tolerable, and comparatively safe and effective alternative to drugs and invasive surgery, which carry greater risk of undesirable or significant side effects and complications, including death.

While current economic conditions continue to restrain market growth, the U.S. market for minimally invasive bariatric surgical devices is expected to exhibit relatively good growth over the next 5 years. Valued at an estimated $147.5 million in 2010, the U.S. minimally invasive benign prostatic hyperplasia therapy systems market is expected to increase at a compound annual rate of 2.4%, with sales reaching more than $166 million in 2015. The largest segment, laser BPH therapy, is expected to drive market growth over the forecast period—expanding at a comparatively higher rate of 4.6%—at the expense of minimally invasive office-based therapies.

This dynamic market report from Medtech Insight includes analyses of products, markets, competitors, and emerging technology and opportunities.
Topics in this report include transurethral microwave thermotherapy (TUMT); transurethral needle ablation (TUNA); holmium laser ablation of the prostate (HoLAP); photoselective vaporization of the prostate (PVP), or Greenlight Laser Therapy; transurethral resection of the prostate (TURP); and the only other totally non-invasive energy-based technology is the Biophysica Prostate Shrinker. Medtech report is available at

Prostate Supplements:

Prostate Revive is an all-natural dietary supplement containing 15 special ingredients targeted towards improving and sustaining normal prostate function from Dr David Brownstein at


Nutritional Supplements for the Prostate in one capsule from Dr Fred Prologic at

1.     saw palmetto berry extract

2.     cranberry works on bladder and kidney 1000 mg

3.     green tea extract

4.     beta-sitosterol

5.     lycopene antioxidant

6.     stinging nettle root

7.     pygeum africanum bark

8.     pumkin seeds

9.     Zinc for inflammation and the Immune System 10mg

10.  Hydrangea root powder

11.  Copper  3mg

12.  Selenium 0.2 mg

13.  Boswellia Gum

14.  Vitamin E

15.  Vitamin D3 1000 IU

16.  Pomegranate fruit


Vibration may help heal chronic wounds Posted: 01 Apr 2014 at The Watchers.
Our prostatherm has vibration as one of the energies included.

Wounds may heal more quickly if exposed to low-intensity vibration, report researchers at the University of Illinois at Chicago. The finding, in mice, may hold promise for the 18 million Americans who have type 2 diabetes, and especially the quarter of them who will eventually suffer from foot ulcers. Their wounds tend to heal slowly and can become chronic or worsen rapidly. Timothy Koh, UIC professor of kinesiology and nutrition in the UIC College of Applied Health Sciences, was intrigued by studies at Stony Brook University in New York that used very low-intensity signals to accelerate bone regeneration. "This technique is already in clinical trials to see if vibration can improve bone health and prevent osteoporosis," Koh said. Koh and his coworkers at UIC... Read more »

 Prostate References:

  1. Prostate Enlargement/BPH Health Center at
  2. Will hyperthermia conquer the elusive hypoxic cell? Implications of heat effects on tumor and normal-tissue microcirculation.   Dewhirst MW, Ozimek EJ, Gross J, Cetas TC. Radiology. 1980 Dec;137(3):811-7.  Abstract: In tumor radiobiology, the hypoxic cell has become especially important because of recent evidence of acute hypoxic regions within experimental tumors. The impact of hyperthermia on the development of acute hypoxia is discussed. Two experiments for studying hyperthermia and hypoxia in tumors are presented. Knowledge of the microenvironment of tumor cells will be necessary to understand and improve tumor control.
  3. Harris AL. Hypoxia--a key regulatory factor in tumour growth. Nature reviews. 2002;2:38–47.
  4. Hockel M, Vaupel P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. Journal of the National Cancer Institute. 2001;93:266–276. [PubMed]
  5. Vaupel P. Tumor microenvironmental physiology and its implications for radiation oncology. Seminars in radiation oncology. 2004;14:198–206. [PubMed]
  6. Brizel DM, Scully SP, Harrelson JM, et al. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer research. 1996;56:941–943. [PubMed]
  7. Reinhold HS, Endrich B. Tumour microcirculation as a target for hyperthermia. Int J Hyperthermia. 1986;2:111–137. [PubMed]
  8. Hall EJ, Roizin-Towle L. Biological effects of heat. Cancer research. 1984;44:4708s–4713s. [PubMed]
  9. Vernon CC, Hand JW, Field SB, et al. Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. International Collaborative Hyperthermia Group. International journal of radiation oncology, biology, physics. 1996;35:731–744.
  10. van der Zee J, Gonzalez Gonzalez D, van Rhoon GC, van Dijk JD, van Putten WL, Hart AA. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet. 2000;355:1119–1125. [PubMed]
  11. Harima Y, Nagata K, Harima K, Ostapenko VV, Tanaka Y, Sawada S. A randomized clinical trial of radiation therapy versus thermoradiotherapy in stage IIIB cervical carcinoma. Int J Hyperthermia. 2001;17:97–105. [PubMed]
  12. van der Zee J, van Rhoon GC. Cervical cancer: radiotherapy and hyperthermia. Int J Hyperthermia. 2006;22:229–234. [PubMed]
  13. Song CW, Park H, Griffin RJ. Improvement of tumor oxygenation by mild hyperthermia. Radiation research. 2001;155:515–528. [PubMed]
  14. Shakil A, Osborn JL, Song CW. Changes in oxygenation status and blood flow in a rat tumor model by mild temperature hyperthermia. International journal of radiation oncology, biology, physics. 1999;43:859–865.
  15. Vujaskovic Z, Poulson JM, Gaskin AA, et al. Temperature-dependent changes in physiologic parameters of spontaneous canine soft tissue sarcomas after combined radiotherapy and hyperthermia treatment. International journal of radiation oncology, biology, physics. 2000;46:179–185.
  16. Brizel DM, Scully SP, Harrelson JM, et al. Radiation therapy and hyperthermia improve the oxygenation of human soft tissue sarcomas. Cancer research. 1996;56:5347–5350. [PubMed]
  17. Vujaskovic Z, Rosen EL, Blackwell KL, et al. Ultrasound guided pO2 measurement of breast cancer reoxygenation after neoadjuvant chemotherapy and hyperthermia treatment. Int J Hyperthermia. 2003;19:498–506. [PubMed]
  18. Ljungkvist AS, Bussink J, Kaanders JH, van der Kogel AJ. Dynamics of tumor hypoxia measured with bioreductive hypoxic cell markers. Radiation research. 2007;167:127–145. [PubMed]
  19. Ljungkvist AS, Bussink J, Kaanders JH, et al. Hypoxic cell turnover in different solid tumor lines. International journal of radiation oncology, biology, physics. 2005;62:1157–1168.
  20. 18. Ljungkvist AS, Bussink J, Rijken PF, Raleigh JA, Denekamp J, Van Der Kogel AJ. Changes in tumor hypoxia measured with a double hypoxic marker technique. International journal of radiation oncology, biology, physics. 2000;48:1529–1538.
  21. Ljungkvist AS, Bussink J, Kaanders JH, Wiedenmann NE, Vlasman R, van der Kogel AJ. Dynamics of hypoxia, proliferation and apoptosis after irradiation in a murine tumor model. Radiation research. 2006;165:326–336. [PubMed]
  22. Lord EM, Harwell L, Koch CJ. Detection of hypoxic cells by monoclonal antibody recognizing 2-nitroimidazole adducts. Cancer research. 1993;53:5721–5726. [PubMed]
  23. Kleiter MM, Thrall DE, Malarkey DE, et al. A comparison of oral and intravenous pimonidazole in canine tumors using intravenous CCI-103F as a control hypoxia marker. International journal of radiation oncology, biology, physics. 2006;64:592–602.
  24. Urano M, Gerweck LE, Epstein R, Cunningham M, Suit HD. Response of a spontaneous murine tumor to hyperthermia: factors which modify the thermal response in vivo. Radiation research. 1980;83:312–322. [PubMed]
  25. Shin KH, Diaz-Gonzalez JA, Russell J, et al. Detecting changes in tumor hypoxia with carbonic anhydrase IX and pimonidazole. Cancer Biol Ther. 2007;6:70–75. [PubMed]
  26. Li XF, Carlin S, Urano M, Russell J, Ling CC, O'Donoghue JA. Visualization of hypoxia in microscopic tumors by immunofluorescent microscopy. Cancer research. 2007;67:7646–7653. [PubMed]
  27. Song CW, Shakil A, Osborn JL, Iwata K. Tumour oxygenation is increased by hyperthermia at mild temperatures. Int J Hyperthermia. 1996;12:367–373. [PubMed]
  28. Horsman MR, Overgaard J. Can mild hyperthermia improve tumour oxygenation? Int J Hyperthermia. 1997;13:141–147. [PubMed]
  29. Okajima K, Griffin RJ, Iwata K, Shakil A, Song CW. Tumor oxygenation after mild-temperature hyperthermia in combination with carbogen breathing: dependence on heat dose and tumor type. Radiation research. 1998;149:294–299. [PubMed]
  30. Thrall DE, Larue SM, Pruitt AF, Case B, Dewhirst MW. Changes in tumour oxygenation during fractionated hyperthermia and radiation therapy in spontaneous canine sarcomas. Int J Hyperthermia. 2006;22:365–373. [PubMed]
  31. Song CW. Modification of blood flow. In: Molls M, Vauple P, editors. Blood perfusion and microenvironment of human tumors. Berlin: Springer-Verlag; 1998. pp. 193–207.
  32. Song CW, Park HJ, Lee CK, Griffin R. Implications of increased tumor blood flow and oxygenation caused by mild temperature hyperthermia in tumor treatment. Int J Hyperthermia. 2005;21:761–767.
  33. The optimal combination of hyperthermia and carbogen breathing to increase tumor oxygenation and radiation response. Griffin RJ, Okajima K, Song CW. Int J Radiat Oncol Biol Phys. 1998 Nov 1;42(4):865-

33.  Br J Cancer Suppl. 1996 Jul;27:S217-21.

34.  Int J Hyperthermia. 2006 Mar;22(2):93-115.

35.  The effect of mild temperature hyperthermia on tumour hypoxia and blood perfusion: relevance for radiotherapy, vascular targeting and imaging. Sun X, Xing L, Ling CC, Li GC.Int J Hyperthermia. 2010;26(3):224-31.

  1. Radiat Res. 2001 Apr;155(4):515-28.


Prostate Links:


1.   How The Heating Effect In Magnetic Hyperthermia Works As A Cancer Treatment in Medical News, 17 Jul 2013, When the temperature rises above 42ºC cells begin to die. This heating process has been demonstrated to reduce tumour size.

 A Better Probe for Prostate Cancer Diagnosiscombines two optical techniques

2.   Heat treatment kills cancer cells: researchers at Johns Hopkins University conclude heat therapy may be a viable treatment for testicular cancer.

3.Prostate biopsy cause serious bleeding and infection-related complications, causing hospitalizations and death, Friday, September 23, 2011 at

4.Improvement of tumor oxygenation by mild hyperthermia. Song CW, Park H, Griffin RJ.

5.     Monitoring the effect of mild hyperthermia on tumour hypoxia by Cu-ATSM PET scanning. Myerson RJ, Singh AK, Bigott HM, Cha B, Engelbach JA, Kim J, Lamoreaux WT, Moros E, Novak P, Sharp TL, Straube W, Welch MJ, Xu M.

6.    Tumour oxygenation is increased by hyperthermia at mild temperatures. Song CW, Shakil A, Osborn JL, Iwata K. Int J Hyperthermia. 1996 May-Jun;12(3):367-73.

7.     Tumour oxygenation is increased by hyperthermia at mild temperatures. 1996. Song CW, Shakil A, Osborn JL, Iwata K. Int J Hyperthermia. 2009 Mar;25(2):91-5.

8.     Can mild hyperthermia improve tumour oxygenation? Horsman MR, Overgaard J. Int J Hyperthermia. 1997 Mar-Apr;13(2):141-7.

9.     Tumour pO2 can be increased markedly by mild hyperthermia. Iwata K, Shakil A, Hur WJ, Makepeace CM, Griffin RJ, Song CW.

10.  Strong synergy of heat and modulated electromagnetic field in tumor cell killing. Andocs G, Renner H, Balogh L, Fonyad L, Jakab C, Szasz A.

11. Strahlenther Onkol. 2009 Feb;185(2):120-6. Epub 2009 Feb 25.

12. Effect of hyperthermia on hypoxic cell fraction in tumor. Song CW, Rhee JG, Levitt SH. Int J Radiat Oncol Biol Phys. 1982 May;8(5):851-6.

13.  Changes in tumour oxygenation during fractionated hyperthermia and radiation therapy in spontaneous canine sarcomas. Thrall DE, Larue SM, Pruitt AF, Case B, Dewhirst MW. Int J Hyperthermia. 2006 Aug;22(5):365-73.

14.  Changes in tumor oxygenation after localized microwave heating. Vaupel P, Otte J, Manz R. Prog Clin Biol Res. 1982;107:65-74.

15. Changes in tumor hypoxia induced by mild temperature hyperthermia as assessed by dual-tracer immunohistochemistry. Sun X, Li XF, Russell J, Xing L, Urano M, Li GC, Humm JL, Ling CC. Radiother Oncol. 2008 Aug;88(2):269-76. Epub 2008 Jun 5.

16.Changes in oxygenation status and blood flow in a rat tumor model by mild temperature hyperthermia. Shakil A, Osborn JL, Song CW. Int J Radiat Oncol Biol Phys. 1999 Mar 1;43(4):859-65.

17.  Changes in tumor hypoxia induced by mild temperature hyperthermia 42–43°C. Hypoxia and low perfusion contribute to malignant progression. MTH effectively improved oxygenation and enhanced the response of tumors to radiotherapy, and improved local tumor control and patient survival, Sun, X. Li, X. Russell, J. Ling, C at Radiother Oncol. 2008 August; 88(2): 269–276.  and at

18.  Minimally Invasive Benign Prostatic Hyperplasia Therapy Systems Market (May 2011) at

19.  Hyperthermia treatments at

20.  Prostate treatments Comprehensive study Special to at

21.FDA APPROVES NEW DEVICE TO TREAT ENLARGED PROSTATE.  Microwaves to heat and destroy excess prostate tissue at

22.  U.S. Minimally Invasive Benign Prostatic Hyperplasia Therapy Systems Market at

23. BSD Medical Announces Successful Initiation of Hyperthermia Cancer Treatment (cervical cancer) at

24. Tumour Treating Fields: FDA approves the treatment of brain tumors with electrical fields called Tumour Treating Fields: Tests with 20 different tumour cell types indicate that the devices can slow and reverse tumor growth by inhibiting mitosis, the process by which cancerous cells divide and replicate. The Novocure treatment involves placing pads onto the patient's skin that creates a low intensity, alternating electric field within the tumor. The electric field prevents the normal mitotic process, rapid division of cancer cells and causes cancer cell death (apoptosis) prior to division without harming healthy cells.  The results from a 237-patient trial indicated that Novocure treated patients achieved comparable median overall survival times to patients treated with chemotherapy but had fewer side effects, and reported an improved quality of life.  Therapy is administered continuously over many hours per day. Link to

25.  Scientists destroy tumors in mice using light therapy

  1. Prostate Health News: 10 powerful nutrients that work together for ultimate prostate protection from Al Sears, MD
  2. Prostate biopsy complications soar, causing hospitalizations and death (12 times greater risk of dying compared to men who did not have biopsies), September 23, 2011 at
  3. Vibration benefits:

Additional Publications added March 21, 2014

  1. Tumor Treating Fields (TTF) therapy has been well researched and recently gained FDA approval for brain tumours.
  2. “An Electrical Awakening” by Helen Thomson, New Scientist, March 1, 2014, Issue No 2958
  3. “The Healing Spark: Electric Medicine” by Linda Geddes, Cover story in New Scientist, February 22, 2014, Issue No 2957
  4. “On résiste à l'invasion des armées; on ne résiste pas à l'invasion des idées”. No army can stop an idea whose time has come, Victor Hugo 1852.
  5. General Pre-Clinical Research
    Kirson et al. “Disruption of Cancer Cell Replication by Alternating Electric Fields.Cancer Research, May 1, 2004 64; 3288.
  6. Breast Cancer Feasibility Study1
    Schneiderman et al. “Synergism between chemotherapy and alternating electric fields (TTFields) in cancer cell proliferation inhibition and solid tumor treatment.” Poster presented at AACR Annual Meeting, April 12-16, 2008.
  7. Solid Tumor Feasibility Study
    Salzberg et al. “A Pilot Study with Very Low-Intensity, Intermediate-Frequency Electric Fields in Patients with Locally Advanced and/or Metastatic Solid Tumors.Onkologie 2008;31:362-365
  8. TTF Therapy Synergism with Chemotherapy Pre-Clinical Research
    Kirson et al. “Chemotherapeutic treatment efficacy and sensitivity are increased by adjuvant alternating electric fields (TTFields)”. BMC Medical Physics, January 8, 2009, Vol. 9:1.
  9. Metastatic Tumor Pre-Clinical Research
    Kirson et al. “Alternating electric fields (TTFields) inhibit metastatic spread of solid tumors to the lungs.Clinical and Experimental Metastasis, Volume 26, Number 7, 633-640.
  10. Multi-Drug Resistant Pre-Clinical Research:
    Schneiderman et al. “TTFields alone and in combination with chemotherapeutic agents effectively reduce the viability of MDR cell sub-lines that over-express ABC transporters.BMC Cancer 2010, Vol. 10: 229.
  11. Kinetic Modeling of Time to TTF Effect in Solid Tumors:
    Kirson, E.D., et al., "Modeling tumor growth kinetics and its implications for TTFields treatment planning" in The 2010 SNO Scientific Meeting and Education Day. 2010: Montreal, Canada.
  12. TTF Therapy Review
  13. Pless, M, et al., “Tumor treating fields: concept, evidence and future.” Expert Opin Investig Drugs. 2011 Aug;20(8):1099-106.
  14. Kirson et al. “Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors.Proceedings of the National Academy of Sciences, June 12, 2007 vol. 104 no. 24 10152-10157.

Newly Diagnosed Glioblastoma Brain Tumors1

  1. Kirson et al. “Chemotherapeutic treatment efficacy and sensitivity are increased by adjuvant alternating electric fields (TTFields).BMC Medical Physics January 8, 2009, 9:1.
  2. Pless et al. “A phase II study of tumor treating fields (TTFields) in combination with pemetrexed for advanced non small cell lung cancer (NSCLC).Ann Oncol (2010) 21(suppl 8): viii122-viii161.
  3. Weinberg et al. “A phase I study of Tumor Treating Fields (TTFields) in combination with pemetrexed for pretreated advanced non small cell lung cancer.” Poster Presented at European Respiratory Society Annual Congress, September 18-22, 2010.


- E-mail:

To order any of our products, phone or e-mail us

  Payment:  We accept rapid safe payment through Paypal or by bank transfer.  You can safely use your credit card without revealing the number to any merchant.  We can send you an invoiced link from our Paypal account. Paypal is the world's largest Internet bank and is owned by e-Bay.

Contact:  Biophysica Inc., We are located in Toronto, Ont, Canada  

Our Technical Support Hotline, Phone: (514) 748-8653 or Toll Free 1-800-488-2032 from Canada, US and Territories (10am to 10pm Eastern Standard Time)

Biophysica specialises in Alternative Medicine, Water Sciences, Water Disinfection, water purifiers, safe Antimicrobial Technology, Chlorine-free drinking water, Chlorine-free swimming pool water, electronic water descalers, electromagnetic fuel conditioning, lasers, crystals, Energy Medicine, Energy psychology and Subtle Energy related devices of a preventive, non-invasive nature. Biophysica researches innovative prototype medical devices, and can design both conventional equipment as well as unusual products for public consumers, health professionals, and manufacturers. Please visit our sister site for other Subtle Energy devices at and

e-mail: biophysica at gmail dot com with copy to info at biophysica dot com

Return to Home page

Home  |About us |  Contact us SitemapOur ProductsShipping, Billing and Payment Terms  |Privacy |Warranty, Returns and Repairs

©Biophysica Incorporated

Disclaimer: Our electric and magnetic devices emit energies that are similar to established proven technologies, are designed to achieve equal results and may be helpful in similar situations.  Our specific devices have not been subjected to external scientific studies and are custom built for personal use or experimental and research electro-physiological uses only.

Having Trouble With e-mailing us?

Note to AOL and similar members: Make sure your AOL Mail Controls are set to receive e-mails from  If you have internet e-mail blocked, you will need to update your AOL Mail Controls. To make this update, enter the AOL Keyword "Mail Controls" on AOLAOL and some others block our mail from time to time, so please arrange to have another email address and please send this to us.